Abaxis (ABAX) Declares $0.11 Quarterly Dividend; 0.9% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2016, Declares Quarterly Cash Dividend
January 28, 2016 4:01 PM ESTUNION CITY, Calif., Jan. 28, 2016 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the third fiscal quarter ended December 31, 2015.
Third quarter highlights include:
Total medical and veterinary reagent disc sales of 2.3 million units, up 12% over last year's comparable quarter. International revenues of $11.8 million, up 12% over last year's comparable quarter. Gross profit from continuing operations of $29.6 million, up 3% over last year's comparable quarter. Income from... More